BDP1 as a biomarker in serous ovarian cancer
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5388
Abstract: TFIIIB, an RNA polymerase III specific transcription factor has been found to be deregulated in human cancers with much of the research focused on the TBP, BRF1, and BRF2 subunits. To date, the TFIIIB specific… read more here.
Keywords: bdp1 biomarker; ovarian cancer; serous ovarian; biomarker serous ... See more keywords